On Monday, the drugmaker Merck and a partner, Ridgeback Biotherapeutics, announced they were seeking emergency authorization from the Food and Drug Administration for a new Covid-19 drug. If authorized, the drug, molnupiravir, would be the first antiviral pill to treat Covid-19.
↧